Customized Aptamer Development
Fraunhofer IZI-BB provides the full range of modern SELEX (Systematic Evolution of Ligands by Exponential Enrichment) methods.
These SELEX strategies are tailored to each target and application and can be implemented using either fully or partially automated processes.
The institute thus provides efficient, fast and reliable solutions for a wide range of applications – from research to product development.
- Efficient and targeted aptamer development tailored to specific targets and applications
- A broad range of targets from small molecules and haptens to proteins, toxins, viruses, bacteria and eukaryotic cells
- Target-specific, custom-designed single-stranded DNA and RNA libraries
- Identification of high-affinity and specific aptamers through in-house sequencing, bioinformatics analysis and precise characterization as well as targeted optimization of aptamers based on detailed binding analyses
Our Offer
- Target- and application-specific SELEX strategies, such as cell-based, capture-based and classical (bead-based) SELEX for small molecules, haptens, proteins, toxins, viruses, bacteria and eukaryotic cells.
- Fully or partially automated SELEX procedures ensure high reproducibility and efficiency.
- Parallel selection against different targets or different variants of a target facilitates the identification of promising hits.
- Buffer conditions specifically tailored to the respective application or to real matrices increase the success rate and ensure direct transferability to subsequent assays or sensors.
- Proprietary high-throughput sequencing combined with bioinformatics analysis enables early, data-driven identification of the most promising aptamer candidates and optimal control and monitoring of the SELEX process.
- In-house characterization using modern analytical methods identifies binders with maximum affinity, specificity and optimal application relevance.
Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses IZI-BB